Polaryx Therapeutics, Inc. PLYX
1.80 USD +0.07 (+4.05%)
At closeNov 4, 2026, 4:00 PM EST
1.80 0.00 0.00%
After hours · Nov 4, 4:00 PM ET
1.76 Day range 1.84
1.69 52-week range 48.91
- YTD
- -94.86%
- 1 year
- -94.86%
Financial health
Altman Z-Score
48.59 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
D+1 / 5 overall
- DCF 2
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
Valuation
P/E -184×
FY 2023 5y median -219× FY 2025
P/S 0.0×
FY 2023 5y median 0.0× FY 2025
P/B 363×
FY 2023 5y median 1407× FY 2025
P/FCF -420×
FY 2023 5y median -2576× FY 2025
EV/EBITDA -184×
FY 2023 5y median -218× FY 2025
EV/Sales 0.0×
FY 2023 5y median 0.0× FY 2025
FCF Yield -0.2%
FY 2023 5y median -0.0% FY 2025
Profitability
Gross Margin 0.0%
FY 2023 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2023 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2023 5y median 0.0% FY 2025
ROE -196.8%
FY 2023 5y median -295.9% FY 2025
ROIC -162.4%
FY 2023 5y median -162.4% FY 2025
ROA -165.8%
FY 2023 5y median -165.8% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2023 FY 2025
Operating Income -79.7%
FY 2023 FY 2025
EPS (diluted) -18.8%
FY 2023 FY 2025
Free Cash Flow -53.3%
FY 2023 FY 2025
Financial Health
Current Ratio 8.5×
FY 2023 5y median 8.5× FY 2025
Quick Ratio 8.5×
FY 2023 5y median 8.5× FY 2025
Debt / Equity 0.0×
FY 2023 5y median 0.0× FY 2025
Net Debt / EBITDA 0.6×
FY 2023 5y median 0.2× FY 2025
Interest Coverage 0.0×
FY 2023 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2023 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2023 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31